Timing of influenza antiviral therapy and risk of death in adults hospitalized with influenza-associated pneumonia, FluSurv-NET, 2012-2019.

Autor: Tenforde MW; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Noah KP; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., O'Halloran AC; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kirley PD; California Emerging Infections Program, Oakland, CA, USA., Hoover C; California Department of Public Health, Richmond, California, USA., Alden NB; Colorado Department of Public Health and Environment, Denver, Colorado, USA., Armistead I; Colorado Department of Public Health and Environment, Denver, Colorado, USA., Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA., Yousey-Hindes K; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA., Openo KP; Georgia Emerging Infections Program, Atlanta, Georgia, USA.; Emory University School of Medicine, Atlanta, Georgia, USA.; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA., Witt LS; Georgia Emerging Infections Program, Atlanta, Georgia, USA.; Emory University School of Medicine, Atlanta, Georgia, USA., Monroe ML; Maryland Department of Health, Baltimore, Maryland, USA., Ryan PA; Maryland Department of Health, Baltimore, Maryland, USA., Falkowski A; Michigan Department of Health and Human Services, Lansing, Michigan, USA., Reeg L; Michigan Department of Health and Human Services, Lansing, Michigan, USA., Lynfield R; Minnesota Department of Health, St. Paul, Minnesota, USA., McMahon M; Minnesota Department of Health, St. Paul, Minnesota, USA., Hancock EB; New Mexico Emerging Infections Program, Santa Fe, New Mexico, USA., Hoffman MR; New Mexico Emerging Infections Program, Santa Fe, New Mexico, USA., McGuire S; New York State Department of Health, Albany, New York, USA., Spina NL; New York State Department of Health, Albany, New York, USA., Felsen CB; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., Gaitan MA; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., Lung K; Ohio Department of Health, Columbus, Ohio, USA., Shiltz E; Ohio Department of Health, Columbus, Ohio, USA., Thomas A; Oregon Health Authority, Salem, OR, USA., Schaffner W; Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Talbot HK; Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Crossland MT; Salt Lake County Health Department, Salt Lake City, Utah, USA., Price A; Salt Lake County Health Department, Salt Lake City, Utah, USA., Masalovich S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Adams K; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Holstein R; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sundaresan D; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Uyeki TM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Reed C; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Bozio CH; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Garg S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 22. Date of Electronic Publication: 2024 Aug 22.

The role of the hospital bed in hospital-onset Clostridioides difficile : A retrospective study with mediation analysis.

Autor: Witt LS; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.; Emory Healthcare, Atlanta, Georgia., Howard-Anderson J; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.; Emory Healthcare, Atlanta, Georgia.; Emory Antibiotic Resistance Center, Atlanta, Georgia., Prakash-Asrani R; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia., Overton E; Emory Antibiotic Resistance Center, Atlanta, Georgia., Jacob JT; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.; Emory Healthcare, Atlanta, Georgia.; Emory Antibiotic Resistance Center, Atlanta, Georgia.

Publikováno v: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2024 May; Vol. 45 (5), pp. 599-603. Date of Electronic Publication: 2023 Dec 13.

Discordant antimicrobial susceptibility and polymerase chain reaction (PCR) testing in a Klebsiella pneumoniae isolate with a carbapenemase gene.

Autor: Witt LS; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.; Georgia Emerging Infections Program, Atlanta Veterans' Affairs Medical Center, Decatur, Georgia., Page A; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.; Georgia Emerging Infections Program, Atlanta Veterans' Affairs Medical Center, Decatur, Georgia., Burd EM; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.; Emory Antibiotic Resistance Center, Atlanta, Georgia., Ozturk T; Emory Antibiotic Resistance Center, Atlanta, Georgia., Weiss DS; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.; Emory Antibiotic Resistance Center, Atlanta, Georgia., Ray SM; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.; Georgia Emerging Infections Program, Atlanta Veterans' Affairs Medical Center, Decatur, Georgia., Satola S; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.; Georgia Emerging Infections Program, Atlanta Veterans' Affairs Medical Center, Decatur, Georgia.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.; Emory Antibiotic Resistance Center, Atlanta, Georgia., Gottlieb LB; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.

Publikováno v: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2023 Dec; Vol. 44 (12), pp. 2100-2102. Date of Electronic Publication: 2023 Sep 01.

The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review.

Autor: Witt LS; Division of Infection Diseases, Emory University School of Medicine, Atlanta, GA, USA., Howard-Anderson JR; Division of Infection Diseases, Emory University School of Medicine, Atlanta, GA, USA.; Emory Antibiotic Resistance Group, Emory University, Atlanta, GA, USA., Jacob JT; Division of Infection Diseases, Emory University School of Medicine, Atlanta, GA, USA.; Emory Antibiotic Resistance Group, Emory University, Atlanta, GA, USA., Gottlieb LB; Division of Infection Diseases, Emory University School of Medicine, Atlanta, GA, USA.; Emory Antibiotic Resistance Group, Emory University, Atlanta, GA, USA.

Publikováno v: JAC-antimicrobial resistance [JAC Antimicrob Resist] 2022 Dec 29; Vol. 5 (1), pp. dlac130. Date of Electronic Publication: 2022 Dec 29 (Print Publication: 2023).

'Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance'-authors' response.

Autor: Witt LS; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA 30303, USA., Burd EM; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Emory School of Medicine, Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA., Ozturk T; Emory School of Medicine, Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA., Satola SW; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA 30303, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Emory School of Medicine, Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA., Weiss DS; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA 30303, USA.; Emory School of Medicine, Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA., Jacob JT; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA 30303, USA.; Emory School of Medicine, Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Oct 28; Vol. 77 (11), pp. 3212.